Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Clinical and Antitumor Immune Responses in Relapsed/Refractory Follicular Lymphoma Patients after Intranodal Injections of IFNα-Dendritic Cells and Rituximab: a Phase I Clinical Trial.

Cox MC, Castiello L, Mattei M, Santodonato L, D'Agostino G, Muraro E, Martorelli D, Lapenta C, Di Napoli A, Di Landro F, Cangemi M, Pavan A, Castaldo P, Hohaus S, Donati S, Montefiore E, Berdini C, Carlei D, Monque DM, Ruco L, Prosperi D, Tafuri A, Spadaro F, Sestili P, Spada M, Dolcetti R, Santini SM, Rozera C, Aricò E, Capone I, Belardelli F.

Clin Cancer Res. 2019 Sep 1;25(17):5231-5241. doi: 10.1158/1078-0432.CCR-19-0709. Epub 2019 Jun 6.

PMID:
31171545
2.

Dendritic cells modulate c-kit expression on the edge between activation and death.

Simonetti S, Seijas ABB, Natalini A, Vitale S, Runci D, Soriani A, Di Virgilio A, Aricò E, Gabriele L, Santoni A, Di Rosa F.

Eur J Immunol. 2019 Apr;49(4):534-545. doi: 10.1002/eji.201847683. Epub 2019 Feb 25.

PMID:
30758056
3.

From Traumatic Childhood to Cocaine Abuse: The Critical Function of the Immune System.

Lo Iacono L, Catale C, Martini A, Valzania A, Viscomi MT, Chiurchiù V, Guatteo E, Bussone S, Perrone F, Di Sabato P, Aricò E, D'Argenio A, Troisi A, Mercuri NB, Maccarrone M, Puglisi-Allegra S, Casella P, Carola V.

Biol Psychiatry. 2018 Dec 15;84(12):905-916. doi: 10.1016/j.biopsych.2018.05.022. Epub 2018 Jun 11.

PMID:
30029767
4.

Disruption of IFN-I Signaling Promotes HER2/Neu Tumor Progression and Breast Cancer Stem Cells.

Castiello L, Sestili P, Schiavoni G, Dattilo R, Monque DM, Ciaffoni F, Iezzi M, Lamolinara A, Sistigu A, Moschella F, Pacca AM, Macchia D, Ferrantini M, Zeuner A, Biffoni M, Proietti E, Belardelli F, Aricò E.

Cancer Immunol Res. 2018 Jun;6(6):658-670. doi: 10.1158/2326-6066.CIR-17-0675. Epub 2018 Apr 5.

5.

Engineered exosomes emerging from muscle cells break immune tolerance to HER2 in transgenic mice and induce antigen-specific CTLs upon challenge by human dendritic cells.

Anticoli S, Aricò E, Arenaccio C, Manfredi F, Chiozzini C, Olivetta E, Ferrantelli F, Lattanzi L, D'Urso MT, Proietti E, Federico M.

J Mol Med (Berl). 2018 Feb;96(2):211-221. doi: 10.1007/s00109-017-1617-2. Epub 2017 Dec 27.

PMID:
29282521
6.

Role of interferon regulatory factor 1 in governing Treg depletion, Th1 polarization, inflammasome activation and antitumor efficacy of cyclophosphamide.

Buccione C, Fragale A, Polverino F, Ziccheddu G, Aricò E, Belardelli F, Proietti E, Battistini A, Moschella F.

Int J Cancer. 2018 Mar 1;142(5):976-987. doi: 10.1002/ijc.31083. Epub 2017 Oct 16.

7.

Chemo-immunotherapy induces tumor regression in a mouse model of spontaneous mammary carcinogenesis.

Aricò E, Sestili P, Carpinelli G, Canese R, Cecchetti S, Schiavoni G, D'Urso MT, Belardelli F, Proietti E.

Oncotarget. 2016 Sep 13;7(37):59754-59765. doi: 10.18632/oncotarget.10880.

8.

Social threat exposure in juvenile mice promotes cocaine-seeking by altering blood clotting and brain vasculature.

Lo Iacono L, Valzania A, Visco-Comandini F, Aricò E, Viscomi MT, Castiello L, Oddi D, D'Amato FR, Bisicchia E, Ermakova O, Puglisi-Allegra S, Carola V.

Addict Biol. 2017 Jul;22(4):911-922. doi: 10.1111/adb.12373. Epub 2016 Feb 12.

9.

Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma.

Rozera C, Cappellini GA, D'Agostino G, Santodonato L, Castiello L, Urbani F, Macchia I, Aricò E, Casorelli I, Sestili P, Montefiore E, Monque D, Carlei D, Napolitano M, Rizza P, Moschella F, Buccione C, Belli R, Proietti E, Pavan A, Marchetti P, Belardelli F, Capone I.

J Transl Med. 2015 May 2;13:139. doi: 10.1186/s12967-015-0473-5.

10.

A tumor-promoting mechanism mediated by retrotransposon-encoded reverse transcriptase is active in human transformed cell lines.

Sciamanna I, Gualtieri A, Cossetti C, Osimo EF, Ferracin M, Macchia G, Aricò E, Prosseda G, Vitullo P, Misteli T, Spadafora C.

Oncotarget. 2013 Dec;4(12):2271-87.

11.

Interferon-α as antiviral and antitumor vaccine adjuvants: mechanisms of action and response signature.

Aricò E, Belardelli F.

J Interferon Cytokine Res. 2012 Jun;32(6):235-47. doi: 10.1089/jir.2011.0077. Epub 2012 Apr 10. Review.

PMID:
22490303
12.

Concomitant detection of IFNα signature and activated monocyte/dendritic cell precursors in the peripheral blood of IFNα-treated subjects at early times after repeated local cytokine treatments.

Aricò E, Castiello L, Urbani F, Rizza P, Panelli MC, Wang E, Marincola FM, Belardelli F.

J Transl Med. 2011 May 17;9:67. doi: 10.1186/1479-5876-9-67.

13.

MHV-68 producing mIFNα1 is severely attenuated in vivo and effectively protects mice against challenge with wt MHV-68.

Aricò E, Monque DM, D'Agostino G, Moschella F, Venditti M, Kalinke U, Allen DJ, Stewart JP, Nash AA, Belardelli F, Ferrantini M.

Vaccine. 2011 May 23;29(23):3935-44. doi: 10.1016/j.vaccine.2011.03.092. Epub 2011 Apr 8. Erratum in: Vaccine. 2012 Apr 26;30(20):3145. Stewart, James P [added].

PMID:
21481326
14.

Unraveling cancer chemoimmunotherapy mechanisms by gene and protein expression profiling of responses to cyclophosphamide.

Moschella F, Valentini M, Aricò E, Macchia I, Sestili P, D'Urso MT, Alessandri C, Belardelli F, Proietti E.

Cancer Res. 2011 May 15;71(10):3528-39. doi: 10.1158/0008-5472.CAN-10-4523. Epub 2011 Mar 28.

15.

Activation of TNF receptor 2 in microglia promotes induction of anti-inflammatory pathways.

Veroni C, Gabriele L, Canini I, Castiello L, Coccia E, Remoli ME, Columba-Cabezas S, Aricò E, Aloisi F, Agresti C.

Mol Cell Neurosci. 2010 Nov;45(3):234-44. doi: 10.1016/j.mcn.2010.06.014. Epub 2010 Jun 28.

PMID:
20600925
16.

Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients.

Nisticò P, Capone I, Palermo B, Del Bello D, Ferraresi V, Moschella F, Aricò E, Valentini M, Bracci L, Cognetti F, Ciccarese M, Vercillo G, Roselli M, Fossile E, Tosti ME, Wang E, Marincola F, Imberti L, Catricalà C, Natali PG, Belardelli F, Proietti E.

Int J Cancer. 2009 Jan 1;124(1):130-9. doi: 10.1002/ijc.23886.

17.

Gene expression profile of peripheral blood mononuclear cells in response to HIV-VLPs stimulation.

Buonaguro L, Monaco A, Aricò E, Wang E, Tornesello ML, Lewis GK, Marincola FM, Buonaguro FM.

BMC Bioinformatics. 2008 Mar 26;9 Suppl 2:S5. doi: 10.1186/1471-2105-9-S2-S5.

18.

Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection.

Panelli MC, Stashower ME, Slade HB, Smith K, Norwood C, Abati A, Fetsch P, Filie A, Walters SA, Astry C, Aricó E, Zhao Y, Selleri S, Wang E, Marincola FM.

Genome Biol. 2007;8(1):R8.

19.

Immature monocyte derived dendritic cells gene expression profile in response to Virus-Like Particles stimulation.

Aricò E, Wang E, Tornesello ML, Tagliamonte M, Lewis GK, Marincola FM, Buonaguro FM, Buonaguro L.

J Transl Med. 2005 Dec 29;3:45.

20.

Delayed polarization of mononuclear phagocyte transcriptional program by type I interferon isoforms.

Stroncek DF, Basil C, Nagorsen D, Deola S, Aricó E, Smith K, Wang E, Marincola FM, Panelli MC.

J Transl Med. 2005 Jun 13;3:24.

21.
22.

Humoral immune response and protection from viral infection in mice vaccinated with inactivated MHV-68: effects of type I interferon.

Aricò E, Robertson K, Allen D, Ferrantini M, Belardelli F, Nash AA.

J Interferon Cytokine Res. 2002 Nov;22(11):1081-8.

PMID:
12513907
23.

Type I consensus IFN (IFN-con1) gene transfer into KSHV/HHV-8-infected BCBL-1 cells causes inhibition of viral lytic cycle activation via induction of apoptosis and abrogates tumorigenicity in sCID mice.

D'Agostino G, Aricò E, Santodonato L, Venditti M, Sestili P, Masuelli L, Coletti A, Modesti A, Picchio G, Mosier DE, Ferrantini M, Belardelli F.

J Interferon Cytokine Res. 1999 Nov;19(11):1305-16.

PMID:
10574624

Supplemental Content

Support Center